🔎 Trials Near Me

Beranda › Kanker Orofaring › New York › New York City

Uji klinis Kanker Orofaring di New York City, NY

6 studi untuk Kanker Orofaring mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Menerima pesertaFase 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05136196

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06984861

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT05491512

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT05307939

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT07063212

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

Menerima pesertaFase 2
  • New York University School of Medicine, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jan 2026 · NCT03215719

Uji klinis Kanker Orofaring di kota lain

Studi lain di New York City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.